The underuse of insulin therapy in North America
- 1 September 2002
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 18 (S3) , S42-S49
Abstract
At least 8% of the combined population of the United States (US) and Canada have diabetes, and in about one‐third of these people, the disease is undiagnosed1. Diabetes is not evenly distributed geographically, and there is surprisingly little consensus among categories of medical providers as to when and how intensive insulin therapy should be initiated. Although some physicians worry that insulin therapy may promote insulin resistance or increase the risk of cardiovascular events, the best current clinical evidence suggests that such fears are largely unfounded. Similarly, new evidence shows that the weight gain associated with insulin therapy is by no means always dramatic or progressive. The view that insulin is not effective in type 2 diabetes, although common in the US, is not shared by physicians experienced and skillful in its use and is refuted by recent clinical studies. Promising new patterns of insulin use in type 2 patients are emerging in the US: the availability of insulin as a single dose, rather than moving directly to multiple daily injections; the practice of continuing rather than stopping oral agents when an evening insulin dose is added; and the use of new insulins and insulin‐sensitizing agents that facilitate therapy and increase its effectiveness. Several new treatment options are discussed. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Beginning Insulin Treatment of Obese Patients With Evening 70/30 Insulin Plus Glimepiride Versus Insulin AloneDiabetes Care, 1998
- Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitusBMJ, 1997
- Effect of Intensive Treatment of Diabetes on the Risk of Death or Renal Failure in NIDDM and IDDMDiabetes Care, 1997
- Safety and Efficacy of Normalizing Fasting Glucose With Bedtime NPH Insulin Alone in NIDDMDiabetes Care, 1995
- Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trialDiabetes Care, 1993
- Combined Therapy for Obese Type 2 Diabetes: Suppertime Mixed Insulin with Daytime SulfonylureaThe American Journal of the Medical Sciences, 1992
- Effect of Conventional and Intensified Insulin Therapy on Free-Insulin Profiles and Glycemic Control in NIDDMDiabetes Care, 1992
- The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes MellitusDiabetes, 1985
- Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin WithdrawalDiabetes, 1984